Signum Life Science ApS: Financial statements 2016
CVR: 36559241
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 11,381,989 and a net result of DKK 4,835,572 compared with DKK 2,630,535 the year before. That is an increase of 23.7% compared with the year before. Equity in the 2016 report amounted to DKK 122,516,068. The solvency ratio was 84.2%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 11,381,989
- Profit/Loss
- DKK 4,835,572
- Equity
- DKK 122,516,068
- Total Assets
- DKK 145,527,437
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 11.4M | 4.8M | 122.5M | 16 |
| 2015 | - | 9.2M | 2.6M | 119.5M | 16 |
Official annual report
Find more companies like Signum Life Science ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
Signum Life Science ApS has published its annual report for 2015. Gross profit came to DKK 9,203,931, and the net result was DKK 2,630,535.
As of April 6, 2016, Mads Tang Dalsgaard has joined the board of directors of Signum Life Science ApS.
As of April 6, 2016, Lone Henriette Andreasen has left the board of directors of Signum Life Science ApS.
As of March 29, 2016, Thomas Gross Nødvig has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Jan Fritzbøger has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Christophe Duret has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Carina Schaldemose Sørensen has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Jan Ulrik Stevnsborg has left the board of directors of Signum Life Science ApS.
As of March 28, 2016, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.
As of March 28, 2016, Christophe Duret has left the board of directors of Signum Life Science ApS.
About Signum Life Science ApS
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.